MEDIROM Healthcare Technologies Inc.

NasdaqCM:MRM Stock Report

Market Cap: US$7.3m

MEDIROM Healthcare Technologies Future Growth

Future criteria checks 4/6

MEDIROM Healthcare Technologies is forecast to grow earnings and revenue by 122.9% and 13.6% per annum respectively.

Key information

122.9%

Earnings growth rate

n/a

EPS growth rate

Consumer Services earnings growth22.1%
Revenue growth rate13.6%
Future return on equityn/a
Analyst coverage

Low

Last updated03 Feb 2025

Recent future growth updates

Recent updates

Market Cool On MEDIROM Healthcare Technologies Inc.'s (NASDAQ:MRM) Revenues Pushing Shares 27% Lower

Nov 16
Market Cool On MEDIROM Healthcare Technologies Inc.'s (NASDAQ:MRM) Revenues Pushing Shares 27% Lower

Some MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) Shareholders Look For Exit As Shares Take 41% Pounding

Sep 26
Some MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) Shareholders Look For Exit As Shares Take 41% Pounding

There's Reason For Concern Over MEDIROM Healthcare Technologies Inc.'s (NASDAQ:MRM) Price

Aug 02
There's Reason For Concern Over MEDIROM Healthcare Technologies Inc.'s (NASDAQ:MRM) Price

MEDIROM Healthcare Technologies' (NASDAQ:MRM) Returns On Capital Not Reflecting Well On The Business

Dec 14
MEDIROM Healthcare Technologies' (NASDAQ:MRM) Returns On Capital Not Reflecting Well On The Business

Potential Upside For MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) Not Without Risk

Aug 30
Potential Upside For MEDIROM Healthcare Technologies Inc. (NASDAQ:MRM) Not Without Risk

Medirom Healthcare receives non-compliance letter from Nasdaq

Jul 01

Earnings and Revenue Growth Forecasts

NasdaqCM:MRM - Analysts future estimates and past financials data (JPY Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20258,985349N/AN/A1
12/31/20248,474225N/AN/A1
6/30/20247,152-112-1,766-807N/A
3/31/20246,9902-1,660-720N/A
12/31/20236,828115-1,554-632N/A
9/30/20236,84745-1,399-821N/A
6/30/20236,958-25-1,243-1,009N/A
3/31/20236,95662-1,048-848N/A
12/31/20226,954149-852-686N/A
9/30/20226,692-251-742-591N/A
6/30/20226,429-651-633-495N/A
3/31/20225,920-821-652-526N/A
12/31/20215,410-991-671-557N/A
9/30/20214,761-804-542-449N/A
6/30/20214,113-618-413-340N/A
3/31/20213,727-579-442-353N/A
12/31/20203,342-539-471-366N/A
9/30/20203,287-509-556-457N/A
6/30/20203,233-480-642-549N/A
3/31/20203,571-231-327-270N/A
12/31/20193,90817-128N/A
12/31/20183,4336694142N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: MRM is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (2.6%).

Earnings vs Market: MRM is forecast to become profitable over the next 3 years, which is considered above average market growth.

High Growth Earnings: MRM is expected to become profitable in the next 3 years.

Revenue vs Market: MRM's revenue (13.6% per year) is forecast to grow faster than the US market (8.8% per year).

High Growth Revenue: MRM's revenue (13.6% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if MRM's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/02/07 11:37
End of Day Share Price 2025/02/07 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

MEDIROM Healthcare Technologies Inc. is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ashok KumarThinkEquity LLC